Data as of Aug 19
| 0.00 / 0.00%|
ADMA Biologics, Inc. operates as a specialty immune globulin company, which engages in the development and commercialization of human plasma and plasma-derived therapeutics. The company's targeted patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disease or who may be immune-suppressed for medical reasons. It operates through two segments: Plasma Collection Center and Research & Development. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 2, 2006 and is headquartered in Hackensack, NJ.
|Adam S. Grossman||President, Chief Executive Officer & Director|
|Brian Lenz||Chief Financial Officer & Vice President|
|James Mond||Executive VP, Chief Scientific & Medical Officer|